Literature DB >> 19765886

The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading.

Bas W G van Rhijn1, Geert J L H van Leenders, Bert C M Ooms, Wim J Kirkels, Alexandre R Zlotta, Egbert R Boevé, Adriaan C Jöbsis, Theo H van der Kwast.   

Abstract

BACKGROUND: A new grading system for bladder cancer (BCa) was adopted in 2004 to reduce observer variability and provide better prognostic information.
OBJECTIVE: We compared the World Health Organization (WHO) 1973 and 2004 systems for observer variability and prognosis. DESIGN, SETTING, AND PARTICIPANTS: Slides of 173 primary non-muscle-invasive BCa were reviewed two times by four pathologists. MEASUREMENTS: Intra- and interobserver variability were assessed using κ statistics. We determined the mean grade (eg, G1/low malignant potential is 1 grade point, G2/low grade is 2 grade points) of the pathologists per grading cycle. Kaplan-Meier analyses were applied for prediction of recurrence and progression. RESULTS AND LIMITATIONS: For WHO 2004 and 1973 grading, the agreement between the pathologists was 39-74% (κ: 0.14-0.58) and 39-64% (κ: 0.15-0.41), respectively. The intraobserver agreement varied from 71% to 88% (κ: 0.55-0.81). The mean grade of a pathologist was constant (difference below 0.1 grade point) irrespective of the grading system. Conversely, mean-grade differences among the pathologists were high, up to 0.7 grade point. The mean grades for the WHO 2004 system were 0.3-0.5 grade point higher than those of WHO 1973. Mean grade distinguished low and high graders among the pathologists and was strongly linked with risk of progression in each grade category.
CONCLUSIONS: The variation in mean grade among individual pathologists exceeded the grade shift caused by WHO 2004 grading. Knowledge of the pathologist's mean grade allows a better assessment of the prognostic value of grading. Mean grade has the potential to become a tool for quality assurance in pathology.
Copyright © 2009 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19765886     DOI: 10.1016/j.eururo.2009.09.022

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  20 in total

1.  Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer.

Authors:  Willemien Beukers; Raju Kandimalla; Roy G Masius; Marcel Vermeij; Ries Kranse; Geert Jlh van Leenders; Ellen C Zwarthoff
Journal:  Mod Pathol       Date:  2014-11-14       Impact factor: 7.842

2.  Impact of 2004 ISUP/WHO classification on bladder cancer grading.

Authors:  Soum D Lokeshwar; Roberto Ruiz-Cordero; Marie C Hupe; Merce Jorda; Mark S Soloway
Journal:  World J Urol       Date:  2015-04-02       Impact factor: 4.226

Review 3.  Molecular imaging with CARS micro-spectroscopy.

Authors:  Marcus Cicerone
Journal:  Curr Opin Chem Biol       Date:  2016-07-09       Impact factor: 8.822

4.  Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.

Authors:  Burçin Tuna; Kutsal Yörükoglu; Ender Düzcan; Sait Sen; Nalan Nese; Banu Sarsık; Aysegul Akder; Sehnaz Sayhan; Uğur Mungan; Ziya Kirkali
Journal:  Virchows Arch       Date:  2011-04-12       Impact factor: 4.064

5.  Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications.

Authors:  Bas W G van Rhijn; Mireia Musquera; Liyang Liu; André N Vis; Tahlita C M Zuiverloon; Geert J L H van Leenders; Wim J Kirkels; Ellen C Zwarthoff; Egbert R Boevé; Adriaan C Jöbsis; Bharati Bapat; Michael A S Jewett; Alexandre R Zlotta; Theo H van der Kwast
Journal:  Mod Pathol       Date:  2014-11-28       Impact factor: 7.842

Review 6.  Contemporary management of low-risk bladder cancer.

Authors:  Johannes Falke; J Alfred Witjes
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

7.  Bladder cancer: validity of the 2004 system for grading Ta bladder cancer.

Authors:  Maximilian Burger; Peter J Goebell
Journal:  Nat Rev Urol       Date:  2012-02-14       Impact factor: 14.432

8.  Interobserver agreement of confocal laser endomicroscopy for bladder cancer.

Authors:  Timothy C Chang; Jen-Jane Liu; Shelly T Hsiao; Ying Pan; Kathleen E Mach; John T Leppert; Jesse K McKenney; Robert V Rouse; Joseph C Liao
Journal:  J Endourol       Date:  2013-02-14       Impact factor: 2.942

9.  Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder.

Authors:  Heejeong Lee; Sun-Young Jun; Youn-Soo Lee; Hee Jin Lee; Weon Sun Lee; Chul Soo Park
Journal:  Virchows Arch       Date:  2013-12-04       Impact factor: 4.064

10.  The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer.

Authors:  Zhongqing Chen; Weihong Ding; Ke Xu; Jun Tan; Chuanyu Sun; Yuancheng Gou; Shijun Tong; Guowei Xia; Zujun Fang; Qiang Ding
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.